CDMO(Delisted)
Avid BioservicesยทNASDAQ
--
--(--)
Is CDMO undervalued or overvalued?
- CDMO scores 0.00/10 on fundamentals and holds a Fair valuation at present. Backed by its -43.41% ROE, -101.07% net margin, 0.00 P/E ratio, 0.00 P/B ratio, and -1168.42% earnings growth, these metrics solidify its Neutral investment rating.
